Registro:

Referencias:

• De Kloet, E.R., Joels, M., Holsboer, F., Stress and the brain: From adaptation to disease (2005) Nat Rev Neurosci, 6, pp. 463-475
• Binder, E.B., The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders (2009) Psychoneuroendocrinology, 34, pp. S186-S195
• Cheung-Flynn, J., Roberts, P.J., Riggs, D.L., Smith, D.F., C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90 (2003) J Biol Chem, 278, pp. 17388-17394
• Sinars, C.R., Cheung-Flynn, J., Rimerman, R.A., Scammell, J.G., Smith, D.F., Clardy, J., Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes (2003) Proc Natl Acad Sci USA, 100, pp. 868-873
• Wochnik, G.M., Ruegg, J., Abel, G.A., Schmidt, U., Holsboer, F., Rein, T., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells (2005) J Biol Chem, 280, pp. 4609-4616
• Touma, C., Gassen, N.C., Herrmann, L., Cheung-Flynn, J., Bull, D.R., Ionescu, I.A., FK506 binding protein 5 shapes stress responsiveness: Modulation of neuroendocrine reactivity and coping behavior (2011) Biol Psychiatry, 70, pp. 928-936
• Davies, T.H., Ning, Y.M., Sanchez, E.R., A new first step in activation of steroid receptors: Hormone-induced switching of FKBP51 and FKBP52 immunophilins (2002) J Biol Chem, 277, pp. 4597-4600
• Riggs, D.L., Roberts, P.J., Chirillo, S.C., Cheung-Flynn, J., Prapapanich, V., Ratajczak, T., The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo (2003) EMBO J, 22, pp. 1158-1167
• Storer, C.L., Dickey, C.A., Galigniana, M.D., Rein, T., Cox, M.B., FKBP51 and FKBP52 in signaling and disease (2011) Trends Endocrinol Metab, 22, pp. 481-490
• Fani, N., Gutman, D., Tone, E.B., Almli, L., Mercer, K.B., Davis, J., FKBP5 and attention bias for threat: Associations with hippocampal function and shape (2013) JAMA Psychiatry, 70, pp. 392-400
• Hay, R.T., SUMO: A history of modification (2005) Mol Cell, 18, pp. 1-12
• Geiss-Friedlander, R., Melchior, F., Concepts in sumoylation: A decade on (2007) Nat Rev Mol Cell Biol, 8, pp. 947-956
• Liberman, A.C., Druker, J., Refojo, D., Holsboer, F., Arzt, E., Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells (2009) FASEB J, 23, pp. 1558-1571
• Kadmiel, M., Cidlowski, J.A., Glucocorticoid receptor signaling in health and disease (2013) Trends Pharmacol Sci, 34, pp. 518-530
• Antunica-Noguerol, M., Aprile-Garcia, F., Budziski, M.L., Proto-Cassina, L., Liberman, A.C., Arzt, E., The interplay between the glucocorticoid receptor activity and post-translational modifications in the immune and neuroendocrine systems (2014) Adv Neuroimmune Biol, 5, pp. 19-32
• Tian, S., Poukka, H., Palvimo, J.J., Janne, O.A., Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor (2002) Biochem J, 367, pp. 907-911
• Holmstrom, S.R., Chupreta, S., So, A.Y., Iniguez-Lluhi, J.A., SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX (2008) Mol Endocrinol, 22, pp. 2061-2075
• Druker, J., Liberman, A.C., Antunica-Noguerol, M., Gerez, J., Paez-Pereda, M., Rein, T., RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity (2013) Mol Cell Biol, 33, pp. 2116-2127
• Mollapour, M., Bourboulia, D., Beebe, K., Woodford, M.R., Hoang, P.S., Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors (2014) Mol Cell, 53, pp. 317-329
• Guidotti, G., Calabrese, F., Anacker, C., Racagni, G., Pariante, C.M., Riva, M.A., Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: Modulation by antidepressant treatment (2013) Neuropsychopharmacology, 38, pp. 616-627
• Bonfiglio, J.J., Inda, C., Senin, S., Maccarrone, G., Refojo, D., Giacomini, D., B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells (2013) Mol Endocrinol, 27, pp. 491-510
• Rodriguez, M.S., Dargemont, C., Hay, R.T., SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting (2001) J Biol Chem, 276, pp. 12654-12659
• Sampson, D.A., Wang, M., Matunis, M.J., The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification (2001) J Biol Chem, 276, pp. 21664-21669
• Erlejman, A.G., De Leo, S.A., Mazaira, G.I., Molinari, A.M., Camisay, M.F., Fontana, V., NF-kappaB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A role for peptidyl-prolyl isomerase activity (2014) J Biol Chem, (289), pp. 26263-26276
• Saaltink, D.J., Vreugdenhil, E., Stress, glucocorticoid receptors, and adult neurogenesis: A balance between excitation and inhibition? (2014) Cell Mol Life Sci, 71, pp. 2499-2515
• Obradovic, D., Gronemeyer, H., Lutz, B., Rein, T., Cross-talk of Vitamin D and glucocorticoids in hippocampal cells (2006) J Neurochem, 96, pp. 500-509
• Ma'Ayan, A., Jenkins, S.L., Barash, A., Iyengar, R., Neuro2A differentiation by Galphai/o pathway (2009) Sci Signal, 2, p. cm1
• Tempe, D., Piechaczyk, M., Bossis, G., SUMO under stress (2008) Biochem Soc Trans, 36, pp. 874-878
• Cai, Q., Verma, S.C., Kumar, P., Ma, M., Robertson, E.S., Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification (2010) PLoS One, 5, p. e9720
• Denny, W.B., Valentine, D.L., Reynolds, P.D., Smith, D.F., Scammell, J.G., Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding (2000) Endocrinology, 141, pp. 4107-4113
• Tatro, E.T., Everall, I.P., Kaul, M., Achim, C.L., Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: Implications for major depressive disorder (2009) Brain Res, 1286, pp. 1-12
• Schulke, J.P., Wochnik, G.M., Lang-Rollin, I., Gassen, N.C., Knapp, R.T., Berning, B., Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors (2010) PLoS One, 5, p. e11717
• Anacker, C., Cattaneo, A., Musaelyan, K., Zunszain, P.A., Horowitz, M., Molteni, R., Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis (2013) Proc Natl Acad Sci USA, 110, pp. 8708-8713
• Sarabdjitsingh, R.A., Isenia, S., Polman, A., Mijalkovic, J., Lachize, S., Datson, N., Disrupted corticosterone pulsatile patterns attenuate responsiveness to glucocorticoid signaling in rat brain (2010) Endocrinology, 151, pp. 1177-1186
• Lang, F., Bohmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N., Vallon, V., (Patho) physiological significance of the serum- and glucocorticoid-inducible kinase isoforms (2006) Physiol Rev, 86, pp. 1151-1178
• Yachi, K., Inoue, K., Tanaka, H., Yoshikawa, H., Tohyama, M., Localization of glucocorticoid-induced leucine zipper (GILZ) expressing neurons in the central nervous system and its relationship to the stress response (2007) Brain Res, 1159, pp. 141-147
• Frodl, T., Carballedo, A., Hughes, M.M., Saleh, K., Fagan, A., Skokauskas, N., Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: High IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder (2012) Transl Psychiatry, 2, p. e88
• Henley, J.M., Craig, T.J., Wilkinson, K.A., Neuronal SUMOylation: Mechanisms, physiology, and roles in neuronal dysfunction (2014) Physiol Rev, 94, pp. 1249-1285
• Datwyler, A.L., Lattig-Tunnemann, G., Yang, W., Paschen, W., Lee, S.L., Dirnagl, U., SUMO2/3 conjugation is an endogenous neuroprotective mechanism (2011) J Cereb Blood Flow Metab, 31, pp. 2152-2159
• Tammsalu, T., Matic, I., Jaffray, E.G., Ibrahim, A.F., Tatham, M.H., Hay, R.T., Proteome-wide identification of SUMO2 modification sites (2014) Sci Signal, 7, p. rs2
• Tirard, M., Jasbinsek, J., Almeida, O.F., Michaelidis, T.M., The manifold actions of the protein inhibitor of activated STAT proteins on the transcriptional activity of mineralocorticoid and glucocorticoid receptors in neural cells (2004) J Mol Endocrinol, 32, pp. 825-841
• Ni, L., Yang, C.S., Gioeli, D., Frierson, H., Toft, D.O., Paschal, B.M., FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells (2010) Mol Cell Biol, 30, pp. 1243-1253
• Hubler, T.R., Denny, W.B., Valentine, D.L., Cheung-Flynn, J., Smith, D.F., Scammell, J.G., The FK506- binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness (2003) Endocrinology, 144, pp. 2380-2387
• Lin, D.Y., Huang, Y.S., Jeng, J.C., Kuo, H.Y., Chang, C.C., Chao, T.T., Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors (2006) Mol Cell, 24, pp. 341-354
• Pfander, B., Moldovan, G.L., Sacher, M., Hoege, C., Jentsch, S., SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase (2005) Nature, 436, pp. 428-433
• Gassen, N.C., Hartmann, J., Zschocke, J., Stepan, J., Hafner, K., Zellner, A., Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: Evidence in cells, mice, and humans (2014) PLoS Med, 11, p. e1001755
• Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia (2007) Cell, 131, pp. 309-323
• Liberman, A.C., Antunica-Noguerol, M., Ferraz-De-Paula, V., Palermo-Neto, J., Castro, C.N., Druker, J., Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells (2012) PLoS One, 7, p. e35155
• Desterro, J.M., Rodriguez, M.S., Hay, R.T., SUMO-1 modification of IkappaBalpha inhibits NFkappaB activation (1998) Mol Cell, 2, pp. 233-239
• Tatham, M.H., Jaffray, E., Vaughan, O.A., Desterro, J.M., Botting, C.H., Naismith, J.H., Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9 (2001) J Biol Chem, 276, pp. 35368-35374
• Jaffray, E.G., Hay, R.T., Detection of modification by ubiquitin-like proteins (2006) Methods, 38, pp. 35-38
• Schaaf, M.J., Cidlowski, J.A., Molecular determinants of glucocorticoid receptor mobility in living cells: The importance of ligand affinity (2003) Mol Cell Biol, 23, pp. 1922-1934
• Cheng, J., Wang, D., Wang, Z., Yeh, E.T., SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1 (2004) Mol Cell Biol, 24, pp. 6021-6028
• Chun, T.H., Itoh, H., Subramanian, L., Iniguez-Lluhi, J.A., Nakao, K., Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy (2003) Circ Res, 92, pp. 1201-1208
• Ismail, I.H., Gagne, J.P., Caron, M.C., McDonald, D., Xu, Z., Masson, J.Y., CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage (2012) Nucleic Acids Res, 40, pp. 5497-5510
• Hollenberg, S.M., Evans, R.M., Multiple and cooperative trans-activation domains of the human glucocorticoid receptor (1988) Cell, 55, pp. 899-906
• Rupprecht, R., Arriza, J.L., Spengler, D., Reul, J.M., Evans, R.M., Holsboer, F., Transactivation and synergistic properties of the mineralocorticoid receptor: Relationship to the glucocorticoid receptor (1993) Mol Endocrinol, 7, pp. 597-603
• Naito, T., Momose, F., Kawaguchi, A., Nagata, K., Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits (2007) J Virol, 81, pp. 1339-1349
• Yueh, A., Leung, J., Bhattacharyya, S., Perrone, L.A., De los Santos, K., Pu, S.Y., Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection (2006) J Virol, 80, pp. 342-352
• Barysch, S.V., Dittner, C., Flotho, A., Becker, J., Melchior, F., Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies (2014) Nat Protoc, 9, pp. 896-909

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------